Skip to main content

Breadcrumb

  1. Home

Health Plan

Valid for Measure Submission

Pharmacotherapy Management of COPD Exacerbation (PCE)

  • This measure assesses the percentage of COPD exacerbations for members 40 years of age and older who had an acute inpatient discharge or ED encounter on or between January 1–November 30 of the measurement year and who were dispensed appropriate medications.

    Two rates are reported.
    1. Dispensed a systemic corticosteroid within 14 days of the event
    2. Dispensed a bronchodilator within 30 days of the event

    CBE ID
    0549

Physical Activity in Older Adults (PAO)

  • This measure has two rates that assess the promotion of physical activity in older adults:

    Discussing Physical Activity: Percentage patients 65 years of age and older who reported discussing their level of exercise or physical activity with a doctor or other health provider in the last 12 months

    Advising Physical Activity: Percentage patients 65 years of age and older who reported receiving advice to start, increase, or maintain their level of exercise or physical activity from a doctor or other health provider in the last 12 months

    CBE ID
    0029

Plan All-Cause Readmissions (PCR)

  • For patients 18 years of age and older, the number of acute inpatient stays during the measurement year that were followed by an unplanned acute readmission for any diagnosis within 30 days and the predicted probability of an acute readmission. Data are reported in the following categories:

    1. Count of Index Hospital Stays* (denominator)
    2. Count of 30-Day Readmissions (numerator)
    3. Average Adjusted Probability of Readmission

    *An acute inpatient stay with a discharge during the first 11 months of the measurement year (e.g., on or between January 1 and December 1).

    CBE ID
    1768

Pneumococcal vaccination

  • Percentage of patients with pneumonia, age 65 and older, who were screened for pneumococcal vaccine status and were vaccinated prior to discharge, if indicated

    CBE ID
    0150

Post MI: ACE inhibitor or ARB therapy

  • This measure identifies patients with ST elevation MI (STEMI), or non-ST elevation MI (NSTEMI) plus a history of hypertension, heart failure and/or diabetes prior to the measurement year who are taking an ACEI or an ARB during the measurement year.

    CBE ID
    0594

Potentially Harmful Drug-Disease Interactions in the Elderly

  • The percentage of patients 65 years of age and older who have evidence of an underlying disease, condition or health concern and who are dispensed an ambulatory prescription for a potentially harmful medication, concurrent with or after the diagnosis. Three rates are reported for this measure:
    -Rate 1: The percentage of those with a history of falls that received a potentially harmful medication
    -Rate 2: The percentage of those with dementia that received a potentially harmful medication

    CBE ID
    2993